RENACTIF: Reduction of the Thrombotic Phenotype in Renal Insufficiency With N-AcetylCysteine

NCT03636932 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Diseases

Interventions

DRUG: N-acetylcysteine (NAC)
DRUG: Placebo
BIOLOGICAL: Blood sample
BIOLOGICAL: Blood sample

Sponsor

Assistance Publique Hopitaux De Marseille